National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 47124 [2021-18041]
Download as PDF
<![CDATA[
47124
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices
Emphasis Panel; NIAAA Individual
Fellowship (F30, F31, F32) Review Panel.
Date: October 27, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2109, Bethesda, MD 20892,
(301) 443–8599, espinozala@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience and Behavior
Study Section.
Date: October 28, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2116, MSC 6902, Bethesda, MD
20892, 301–443–0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: August 17, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; The Autoantigens
and Neoantigens Function in the Etiology
and Pathophysiology of T1D.
Date: October 22, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Diabetes and
Digestive and Kidney Diseases, NIH, 6707
Democracy Boulevard, Room 7007, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review
Branch, Division of Extramural Activities,
NIDDK, NIH, 6707 Democracy Boulevard,
Room 7007, Bethesda, MD 20892, Phone:
301–496–7050, tianl@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Development of
Swallowable Smart Pills/Devices (phased
R21/R33).
Date: November 2, 2021.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Diabetes and
Digestive and Kidney Diseases, NIH, 6707
Democracy Boulevard, Room 7007, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review
Branch, Division of Extramural Activities,
NIDDK, NIH, 6707 Democracy Boulevard,
Room 7007, Bethesda, MD 20892, Phone:
301–496–7050, tianl@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17930 Filed 8–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–18041 Filed 8–20–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:11 Aug 20, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; National
Institutes of Health Notice of Meeting
Notice is hereby given of a change in
the meeting of the HEAL (Helping to
End Addiction Long-Term) MultiDisciplinary Working Group, September
01, 2021, 10:30 a.m. to September 02,
2021, 03:45 p.m., National Institutes of
Health, Building 1, Wilson Hall, 1
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Center Drive, Bethesda, MD 20892
which was published in the Federal
Register on August 10, 2021, FR Doc
2021–17012, 86 FR 43669.
This notice is being amended to
update the meeting times for the HEAL
Multi-Disciplinary Working Group
Meeting on September 1–2, 2021. Open:
September 01, 2021, 11:00 a.m. to 12:00
p.m.; Closed: September 01, 2021, 12:00
p.m. to 4:30 p.m.; Closed: September 02,
2021, 11:00 a.m. to 4:30 p.m. The
meeting is partially Closed to the public.
The open portion of the meeting will be
live webcast at: https://
videocast.nih.gov/.
Dated: August 18, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18048 Filed 8–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIGMS Initial Review
Group Training and Workforce Development
Study Section—D NIGMS Review of SuRE
Applications.
Date: October 7–8, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Room 3AN.12F,
Bethesda, MD 20892, 301 594 2886,
tracy.koretsky@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Page 47124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18041]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; The Autoantigens and
Neoantigens Function in the Etiology and Pathophysiology of T1D.
Date: October 22, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Boulevard, Room 7007, Bethesda, MD
20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review Branch, Division of
Extramural Activities, NIDDK, NIH, 6707 Democracy Boulevard, Room
7007, Bethesda, MD 20892, Phone: 301-496-7050, [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Development of
Swallowable Smart Pills/Devices (phased R21/R33).
Date: November 2, 2021.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Boulevard, Room 7007, Bethesda, MD
20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review Branch, Division of
Extramural Activities, NIDDK, NIH, 6707 Democracy Boulevard, Room
7007, Bethesda, MD 20892, Phone: 301-496-7050, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18041 Filed 8-20-21; 8:45 am]
BILLING CODE 4140-01-P
